Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Remimazolam vs Propofol for Hypotension in Elderly Under Spinal Anesthesia
KCT0011444Phase 4Not yet recruiting
- Sponsor
- Hana Pharm
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, remimazolam and propofol (3 arms), sponsored by Hana Pharm. Primary endpoint: Incidence of hypotension. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineremimazolampropofol
Beyond the preview
Go deeper on KCT0011444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011444.